Gmeiner; Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gmeiner; Peter.The latest application filed is for "beta-adrenergic receptor allosteric modulators".
- Gmeiner; Peter - Buckenhof DE
- GMEINER; Peter - Erlangen DE
- Gmeiner; Peter - Erlangen-Buckendorf N/A DE
- Gmeiner; Peter - Erlangen-Buckenhof DE
- Gmeiner; Peter - Mottingen DE
- Gmeiner; Peter - Schwabach DE
| Patent | Date |
|---|---|
| Diagnosis, treatment and prevention of neurotensin receptor-related conditions Grant 11,180,511 - Prante , et al. November 23, 2 | 2021-11-23 |
| Beta-adrenergic Receptor Allosteric Modulators App 20210353626 - SUNAHARA; Roger K. ; et al. | 2021-11-18 |
| Mu Opioid Receptor Modulators App 20210052548 - Shoichet; Brian K. ; et al. | 2021-02-25 |
| Diagnosis, Treatment And Prevention Of Neurotensin Receptor-related Conditions App 20200377523 - PRANTE; Olaf ; et al. | 2020-12-03 |
| Beta-2 Selective Adrenergic Receptor Agonists App 20200360304 - SUNAHARA; Roger ; et al. | 2020-11-19 |
| Fluorophenyl Substituted Muscarinic Receptor Ligands With Selectivity For M3 Over M2 App 20200308168 - BANERJEE; Ashutosh ; et al. | 2020-10-01 |
| Mu opioid receptor modulators Grant 10,780,078 - Shoichet , et al. Sept | 2020-09-22 |
| MU opioid receptor modulators Grant 10,702,498 - Shoichet , et al. | 2020-07-07 |
| Mu Opioid Receptor Modulators App 20200109126 - Shoichet; Brian K. ; et al. | 2020-04-09 |
| Mu Opioid Receptor Modulators App 20190076398 - Shoichet; Brian K. ; et al. | 2019-03-14 |
| Mu Opioid Receptor Modulators App 20190055208 - Shoichet; Brian K. ; et al. | 2019-02-21 |
| Aminotetraline derivatives Grant 8,691,839 - Gmeiner , et al. April 8, 2 | 2014-04-08 |
| Aminotetraline Derivatives App 20130331429 - Gmeiner; Peter ; et al. | 2013-12-12 |
| Aminotetraline derivatives Grant 8,586,603 - Gmeiner , et al. November 19, 2 | 2013-11-19 |
| New Aminotetraline Derivatives App 20120277262 - Gmeiner; Peter ; et al. | 2012-11-01 |
| 9-amino-acridine derivatives and their use for eliminating misfolded proteins Grant 7,951,796 - Korth , et al. May 31, 2 | 2011-05-31 |
| Method and apparatus for operating cooperating, differing devices Grant 7,770,045 - Gmeiner August 3, 2 | 2010-08-03 |
| Indolizines And Aza-analog Derivatives Thereof As Cns Active Compounds App 20100168125 - Gmeiner; Peter ; et al. | 2010-07-01 |
| 9-amino-acridine Derivatives And Method Of Treating Autoimmune Diseases Using The Same App 20090209516 - Korth; Carsten ; et al. | 2009-08-20 |
| Method And Apparatus For Operating Cooperating, Differing Devices App 20090150705 - Gmeiner; Peter | 2009-06-11 |
| 9-amino-acridine Derivatives And Their Use For Eliminating Misfolded Proteins App 20090124001 - Korth; Carsten ; et al. | 2009-05-14 |
| Imaging Device App 20080292051 - Dippl; Thomas ; et al. | 2008-11-27 |
| Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists App 20080194539 - Gmeiner; Peter ; et al. | 2008-08-14 |
| Indolizine Carboxamides and Aza and Diaza Derivatives Thereof App 20080051409 - Gmeiner; Peter ; et al. | 2008-02-28 |
| Azaindole Carboxamides App 20070299091 - Gmeiner; Peter ; et al. | 2007-12-27 |
| Method and device for machining a workpiece Grant 7,292,910 - Gmeiner November 6, 2 | 2007-11-06 |
| Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases App 20050197343 - Gmeiner, Peter ; et al. | 2005-09-08 |
| Method and device for machining a workpiece App 20040111185 - Gmeiner, Peter | 2004-06-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 